Disease-free survival From second randomization to relapse or death, assessed up to 10 years [clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a]

Disease-free survival From second randomization to relapse or death, assessed up to 10 years [clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a]

Analyzed by intention to treat.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a
Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Disease-free survival From second randomization to relapse or death, assessed up to 10 years [clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a]

Analyzed by intention to treat.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a
Bio2RDF identifier
f71167a648fe5e65e60ef763b32e146a
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
From second randomization to relapse or death, assessed up to 10 years
description
Analyzed by intention to treat.
identifier
clinicaltrials_resource:f71167a648fe5e65e60ef763b32e146a
title
Disease-free survival From sec ...... death, assessed up to 10 years
@en
inDataset
type
label
Disease-free survival From sec ...... 167a648fe5e65e60ef763b32e146a]
@en